Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment
A legfontosabb adatok
- Ki végzi
- Xuanwu Hospital, Beijing
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 1000 fő, tervezett
- Kezdés
- 2026. jún. 10.
- Várható befejezés
- 2028. jún. 30.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Intrasaccular Flow Disruption Device
- A regiszteradat frissítve
- 2026. június 11.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for people with a bulge in a brain blood vessel (intracranial aneurysm) treated with the MicroVention Woven EndoBridge (WEB) device in routine care. It collects data from past and new patients.
- Életkor
- Any age.
- Nem
- Any sex.
- A betegség stádiuma
- Intracranial aneurysm treated with a commercially available WEB device.
- Korábbi kezelés
- People must have been treated with a commercially available MicroVention Woven EndoBridge device. Past patients must have had at least one imaging check after the procedure.
A részvétel fő kizáró okai
- Past patients with no imaging data from during or after the procedure cannot join.
- Taking part, or planning to take part, in another study that may affect the results.
- Unable to complete follow-up visits, now or later.
- Life expectancy under 1 year because of other diseases or conditions.
- The study doctor judges the person unfit to take part.
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- Retrospective Cohort:
- Participants of any age and sex
- Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device
- Patients who completed at least one postoperative imaging follow-up; Prospective Cohort:
- Participants of any age and sex
- Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device
- The participant, or legally authorized representative if applicable, understands the study requirements and procedures and provides written informed consent before any study-specific data collection
Ki nem vehet részt
- Patients treated with a Woven EndoBridge device for whom intraoperative or postoperative follow-up imaging data are not available
- Patients with a life expectancy of less than 1 year due to other diseases or conditions
- Retrospective Cohort:
- Patients considered by the investigator to be unsuitable for participation in this study; Prospective Cohort:
- Participants who are currently participating in, or plan to participate during the follow-up period, another clinical study that may affect the results of this study
- Patients who are currently unable or expected to be unable to complete follow-up
- Patients considered by the investigator to be unsuitable for participation in this study
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
We designed the Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment (WEB-RWS), an ambidirectional, multicenter, post-market real-world study with a prospective active surveillance component. The study will include patients with IAs treated with commercially available WEB devices under the direction of treating physicians in routine clinical practice. Clinical, procedural, imaging, and safety data will be collected using a standardized electronic data capture system, with safety events adjudicated by an independent clinical events committee and imaging outcomes assessed by an independent core laboratory. The primary objective is to evaluate 12-month adequate aneurysm occlusion and major adverse events after WEB treatment. The study is expected to provide comprehensive post-market evidence on the real-world performance of the WEB device in China, including its safety, effectiveness, clinical appropriateness, and health economic value in routine neurointerventional practice.
A vizsgálat csoportja
- Patients Treated With the Woven EndoBridge Device
Patients with intracranial aneurysms who are treated with the commercially available MicroVention Woven EndoBridge device as part of routine clinical care. This cohort includes both retrospectively identified patients and prospectively enrolled patients. Clinical, procedural, imaging, safety, effectiveness, clinical appropriateness, and health economic outcomes will be collected according to the study protocol.
Kezelés: Intrasaccular Flow Disruption Device
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Real-World Study of Intrasaccular Flow Disruption Devices for the Treatment of Intracranial Aneurysms
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. június 11.